Why the study?
Does treatment with serotonergic antidepressants increase bleeding complications in elderly patients?
Does treatment with serotonergic antidepressants increase bleeding complications in elderly patients?
Serotonergic antidepressants are associated with an increased risk of bleeding complications in elderly patients, necessitating careful consideration of individual risk factors when prescribing.
Answers are grounded in this paper and cite their sources.
Serotonergic antidepressants may increase bleeding risk in elderly patients; hypothesis-generating for agent-specific effects, pending randomized confirmation.
Literature review on bleeding complications in the course of treatment with antidepressants is presented. We have focused on elderly patients since they are in the high-risk group. Incidence of bleeding complications, causal relation with antidepressants, possible risk factors and methods of prevention are discussed. Presented data indicate that treatment with antidepressants of serotonergic mechanism of action is associated with an increased risk of bleeding complications, which are the most frequent in patients treated with SSRIs, venlafaxine, trazodone and tricyclic antidepressants. The lowest risk is associated with agomelatine, bupropion, reboxetine and mirtazapine. Due to possible serious consequences of bleeding complications, clinicians should consider individual risk factors when choosing antidepressive treatment, particularly in elderly patients.
No takes yet. Share an insight, caveat, or question.
Wysokiński et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: